MedTrace Logo

Acetyl Salicylic Elimination Trial: The ASET Pilot Study

NCT03469856 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-03-19

No results posted yet for this study

Summary

A multicenter, single arm, open-label trial of prasugrel monotherapy after PCI with the new-generation thin-strut biodegradable polymer everolimus-eluting SYNERGY® stent in patients with chronic stable angina

Conditions

  • Monotherapy After PCI

Interventions

DRUG

Prasugrel monotherapy

A multicenter, single arm, open-label trial of in patients with chronic stable angina

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • Cardialysis B.V.

    collaborator INDUSTRY

  • Pedro A. Lemos

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-22
Primary Completion
2019-07-15
Completion
2019-08-15

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03469856 on ClinicalTrials.gov